Good Doctor·Hyperthermic Perfusion | “Elite Pursuit of Excellence” Foundry Program — The 2026 Standardized Spring Training Camp on Intracavitary Hyperthermic Perfusion Therapy (Shanxi Station) Concluded Successfully

“Empowering clinical practice, fostering shared development.” Recently, the two-day “Elite Pursuit of Excellence” Foundry Program—2026 Standardized Spring Training Camp on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Technology (Shanxi Station)—concluded successfully in Taiyuan. Clinical experts from across Shanxi Province gathered to jointly explore advanced techniques and refine diagnostic and therapeutic approaches, marking a new milestone in the standardized implementation of HIPEC throughout the Shanxi region.

“The Furnace Program” is our steadfast commitment to empowering clinical practice and fostering shared development.

This spring training camp is an important continuation of Xi’an Good Doctor Medical’s efforts to extend its reach to local areas and deepen the practical application of its technology, following the previous five sessions on standardized clinical use of hyperthermic perfusion therapy machines. The “Elite Pursuit of Excellence” furnace program embodies Xi’an Good Doctor Medical’s original commitment to training: “Elite” refers to every dedicated medical professional who excels in clinical practice; “Pursuit of Excellence” represents the shared goal of refining skills and striving for excellence; and “Furnace” reflects the philosophy of rigorous refinement and forging exceptional talent. Centered on systematic instruction and standardized hands-on training, the program focuses on standardizing the entire process of intracavitary hyperthermic perfusion therapy, establishing a comprehensive clinical empowerment framework that integrates theory, practical exercises, and assessment, thereby helping regional healthcare professionals hone their skills and align treatment protocols.

“ “Led by renowned experts” is a powerful pillar that enables us to deliver precise empowerment and strengthen our technological foundation.

This training session features a distinguished team of industry-leading experts who will deliver in-person instruction. The program is co‑taught by the founder of the acupuncture‑based microcirculation HIPEC technique and a seasoned expert in deep tumor hyperthermia and whole‑body hyperthermia, alongside Professor Liu, who brings 30 years of international medical experience, and the head nurse of the day‑treatment center, providing participants with cutting‑edge, systematic, and professional clinical guidance.

Figure: A seasoned expert in the fields of deep tumor hyperthermia and whole-body hyperthermia delivered a specialized lecture titled “Clinical Diagnosis and Treatment of Peritoneal Malignant Tumors.” Grounded in the clinical applications of intracavitary hyperthermic perfusion, the course systematically reviewed… Malignant peritoneal tumor Its classification and clinical characteristics are discussed, with a particular focus on the diagnostic and therapeutic challenges posed by peritoneal metastasis as a common and severe complication, in conjunction with the most frequently occurring malignancies. Peritoneal metastasis The data thoroughly elucidate the clinical necessity and core value of intracavitary hyperthermic perfusion therapy.

Figure: Professor Liu, with 30 years of experience in international medical practice, delivers a lecture titled “Research Hotspots in Hyperthermic Intracavitary Perfusion Chemotherapy and the Advantages of GD‑HIPEC.”  
 

The training adopts a small‑class, precision‑teaching model and establishes an integrated “theory + case studies + hands‑on practice” curriculum. The content covers core topics such as the foundational theory of intracavitary hyperthermic perfusion therapy, representative clinical cases, and standardized procedural protocols, with a strong focus on the standardization and practical applicability of the techniques. This approach effectively helps participants strengthen their professional foundation and enhance their clinical skills. At the Shanxi session of this spring training camp, a rigorous dual‑assessment system—comprising a theoretical written exam and a hands‑on skills evaluation—was implemented. All trainees who successfully completed all learning tasks passed the assessments and received certificates of competency, achieving a closed‑loop training process that integrates learning, practice, assessment, and certification.

“Striving for excellence among the elite” is our unwavering commitment to the medical profession.

As a high-tech enterprise integrating R&D, manufacturing, and sales, Xi’an Good Doctor has been deeply engaged in the field of tumor hyperthermia for over a decade, steadfastly upholding its original aspiration to “extend the lives and improve the quality of life of patients with malignant tumors.” Relying on a professional R&D team and extensive clinical experience, it has independently developed a next-generation intracavitary hyperthermic perfusion therapy device. Related research has earned numerous domestic and international invention patents, and the company has established in-depth clinical collaborations with many top-tier hospitals across China.

The Good Doctor intracavitary hyperthermic perfusion therapy machine precisely controls the tumor’s thermobiological characteristics, employing a sustained 42–43°C sub‑hyperthermic intracavitary perfusion for 60 minutes to induce cancer cell apoptosis. Combined with localized perfusion drug delivery, it achieves synergistic enhancement of thermochemotherapy, effectively controlling tumor metastasis and treating malignant pleural or peritoneal effusions. The device utilizes a closed-loop circulation system paired with computer‑assisted, fully automated temperature control, thoroughly addressing the shortcomings of conventional therapies—unstable temperature regulation, uneven heat distribution, and complex operation—and effectively minimizing complications such as intestinal obstruction and adhesions. Backed by clinical validation in over a thousand cases, this equipment demonstrates stable performance, genuinely filling the technical gap in postoperative implantation and metastasis control as well as the treatment of malignant body cavity effusions, making it a reliable choice for clinical diagnosis and treatment.

Currently, the Good Doctor thermal perfusion system has obtained more than 20 proprietary intellectual property rights, with patent coverage spanning multiple regions worldwide. The equipment is compatible with all surgical and medical clinical settings, serving numerous core clinical departments. Thanks to its core advantages of stable temperature control, minimally invasive operation, and high energy efficiency, it has earned widespread recognition and favor from many top-tier Grade III hospitals across China.

“Pragmatic action leads to far-reaching success” is our original aspiration and vision—dedicated to clinical excellence and the safeguarding of health.

This spring training camp concluded successfully, further standardizing the clinical application of intracavitary hyperthermic perfusion therapy in the Shanxi region and injecting new momentum into the high-quality development of local oncology hyperthermia. Moving forward, Xi’an Good Doctor Medical will continue to leverage its technological and R&D strengths, deepen its “Elite Pursuit of Excellence” training program, accelerate the nationwide rollout of standardized regional training, and promote broader coverage and higher‑standard implementation of hyperthermic perfusion therapy. By empowering the tumor diagnosis and treatment system with expertise, it will continue to contribute to safeguarding the health and well-being of the people.